Biochemical Estimation of Glucose 6 Phosphate Dehydrogenase Deficiency in Saudi Adults: Different Methods and Its Rationalization


Background: Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common human enzymopathy affecting 400 million people, globally. G6PD deficiency is an X-linked genetic condition, which is more likely to affect males than females. Heterozygous females go undetected in a commonly used method. The aim of the study was to identify & rationalize different biochemical methods for detections of G6PD deficiency. Methods: Cross section retrospective study was conducted on 1584 (800 males, 784 females) blood samples collected from King Abdulaziz University Hospital (KAUH) and King Fahd Armed force hospital (KFAFH) in Jeddah, Western Saudi Arabia. Blood samples were screened for G6PD activity by fluorescence spot test, semi quantitative color reduction test and spectrometric quantitative evaluation. Hemoglobin (Hb) was measured on the same sample by BC-3200 Auto hematology Analyser. G6PD activity was recorded as U/g Hb. Samples identified as deficient with cutoff ≤4.6 U/gHb. Results: The prevalence of G6PD deficiency identified by fluorescence spot test was 73(4.6%) and all were deficient male. By semi quantitative method, the prevalence rate was 51(3.2%) and again all were male deficit patients. However, when quantitative spectrometric method was used, the prevalence was found in 90(5.7%), where in 73(4.6%) deficient patients were males and 17(1.1%) were females. Conclusion: Since the fluorescence spot test did not miss any G6PD deficient male, it should be restricted to males and quantitative test should be done on females. Each ethnic group should cultivate their own cutoff value for categorization of deficient patients.

Share and Cite:

Jarullah, J. , AlJaouni, S. , Sharma, M. and S. Jarullah, B. (2014) Biochemical Estimation of Glucose 6 Phosphate Dehydrogenase Deficiency in Saudi Adults: Different Methods and Its Rationalization. Advances in Bioscience and Biotechnology, 5, 434-437. doi: 10.4236/abb.2014.55052.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Frank, J.E. (2005) Diagnosis and Management of G6pd Deficiency. American Family Physician, 72, 1277-1282.
[2] Luzzatto, L., Vulliamy, T.J. and Mehta, A. (2001) Glucose 6-Phosphate Dehydrogenase Deficiency. In: Valle, D., Scriver and Beaudet, A.L., The Metabolic and Molecular Bases of Inherited Disease, Sly D, New York, 4517-4534.
[3] World Health Organization (1989) Worldwide Prevalence of G6PD Deficiency According to the World Health Organization with Permission. The Bulletin of the World Health Organization, 67, 601-611.
[4] Ali, A.K. (1996) Common G6PD Variant from Saudi Population and Its Prevalence. Annals of Saudi Medicine, 16, 654-656.
[5] Nasserullah, Z., Al Jame, A., Abu Srair, H., Al Qatari, G., Al Naim, S. and Al Aqib, A. (1998) Neonatal Screening for Sickle Cell Disease, Glucose-6-Phosphate Dehydrogenase Deficiency and a-Thalassemia in Qatif and Al Hasa. Annals of Saudi Medicine, 118, 289-292.
[6] Al-Awamy, B.H., Al-Muzan, M., Al-Turki, M. and Serjeant, G.R. (1984) Neonatal Screening for Sickle Cell Disease in the Eastern Province of Saudi Arabia. Transactions of the Royal Society of Tropical Medicine & Hygiene, 78, 792-794.
[7] Tan, I.K. and Whitehead, T.P. (1969) Automated Fluorometric Determination of Glucose-6-Phosphate Dehydrogenase (G6pd) and 6-Phosphogluconate Dehydrogenase (6pgd) Activities In Red Blood Cells. Clinical Chemistry, 15, 467-478.
[8] Al-Jaouni, S.K., Jarullah, J., Azhar, E. and Moradkhani, K. (2011) Molecular Characterization of Glucose-6-Phosphate Dehydrogenase Deficiency in Jeddah, Kingdom of Saudi Arabia. BMC Research Notes, 4, 436.
[9] Beutler, E., Blume, K.G., Kaplan, C., Lohr, W., Ramot, B. and Valetinine, W.N. (1979) International Committee for Standardization in Hematology Recommended Screening Test for Glucose-6-Phosphate Dehydrogenase. British Journal of Haematology, 43, 469-477.
[10] Jarullah, J, Soad, A.J., Sharma, M., Bushra, M. and Mohammad, A.K. (2012) Detection of Glucose-6-Phosphate Dehydrogenase Deficiency in Heterozygous Saudi Female Neonates. Enzyme Engineering, 1, 2-4.
[11] Duangdao, N., Rick, P., Attakorn, P., Nicholas, P., Nicholas, J.W. and Mallika, I. (2013) Evaluation of the Phenotypic Test and Genetic Analysis in the Detection of Glucose-6-Phosphate Dehydrogenase Deficiency. Malaria Journal, 12, 289.
[12] Reclos, G.J, Hatzidakis, C.J. and Schulpis, K.H. (2000) Glucose-6-Phosphate Dehydrogenase Deficiency Neonatal Screening: Preliminary Evidence That a High Percentage of Partially Deficient Female Neonates Are Missed During Routine Screening. Journal of Medical Screening, 7, 46-51.
[13] Kaplan, M. and Hammerman, C. (2011) Neonatal Screening for Glucose-6-Phosphate Dehydrogenase Deficiency: Biochemical versus Genetic Technologies. Seminars in Perinatology, 35, 155-161.
[14] Wang, F.L., Boo, N.Y. and Ainoon, O. (2009) Comparison of Detection of Glucose-6-Phosphate Dehydrogenase Deficiency Using Fluorescent Spot Test, Enzyme Assay and Molecular Method for Prediction of Severe Neonatal Hyperbilirubinaemia. Singapore Medical Journal, 50, 62-67.
[15] Minucci, A., Giardina, B. and Zuppi, C. (2009) Glucose-6-Phosphate Dehydrogenase Laboratory Assay: How, When, and Why? IUBMB Life, 61, 27-34.
[16] Zaffanello, M, Rugolotto, S. and Zamboni, G. (2004) Neonatal Screening for Glucose-6-Phosphate Dehydrogenase Deficiency Fails to Detect Heterozygote Females. European Journal of Epidemiology, 19, 255-257.
[17] Lin, Z., Fontaine, J.M. and Freer, D.E. (2005) Alternative DNA-Based Newborn Screening for Glucose-6-Phosphate Dehydrogenase Deficiency. Molecular Genetics and Metabolism, 86, 212-219.

Copyright © 2021 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.